IMMUNIC, INC. 8-K

What Happened
Immunic, Inc. (IMUX) filed a Form 8-K on May 13, 2026 reporting its results of operations and financial condition for the quarter ended March 31, 2026. The company furnished a press release (Exhibit 99.1) that announces the quarterly results and provides a corporate update; the filing also includes the Inline XBRL cover page.

Key Details

• Filing date: May 13, 2026 (Form 8-K, Accession No. 0001193805-26-000593).
• Reporting item: Item 2.02 (Results of Operations and Financial Condition).
• Press release: dated May 13, 2026 and furnished as Exhibit 99.1.
• Period covered: quarter ended March 31, 2026 (Q1 2026 quarterly results / earnings).

Why It Matters
This filing signals that Immunic has released its quarterly earnings and a corporate update—information investors use to evaluate recent revenue, expenses, cash position, and program progress. Retail investors should read the May 13 press release and the company’s full SEC filings to see the specific financial figures, commentary on operations, and any updates on clinical or business milestones that could affect the stock.